PAPER Koffie RM, Hyman BT, Spires-Jones TL
SEARCH RESULTS
331007 RESULTS
PAPER Tomono S, Miyoshi N, Ito M, Higashi T, Ohshima H
A highly sensitive LC-ESI-MS/MS method for the quantification of cholesterol ozonolysis products secosterol-A and secosterol-B after derivatization with 2-hydrazino-1-methylpyridine.
J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Sep 15;879(26):2802-8. PubMed: 21871845PAPER Mao P, Reddy PH
Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics.
Biochim Biophys Acta. 2011 Nov;1812(11):1359-70. PubMed: 21871956PAPER Grimm MO, Grösgen S, Riemenschneider M, Tanila H, Grimm HS, Hartmann T
From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin-plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry.
J Chromatogr A. 2011 Oct 21;1218(42):7713-22. PubMed: 21872257PAPER Huang H, Fan X, Weiner M, Martin-Cook K, Xiao G, Davis J, Devous M, Rosenberg R, Diaz-Arrastia R
Distinctive disruption patterns of white matter tracts in Alzheimer's disease with full diffusion tensor characterization.
Neurobiol Aging. 2011 Aug 26; PubMed: 21872362PAPER Liu RT, Tang JT, Zou LB, Fu JY, Lu QJ
Liquiritigenin attenuates the learning and memory deficits in an amyloid protein precursor transgenic mouse model and the underlying mechanisms.
Eur J Pharmacol. 2011 Nov 1;669(1-3):76-83. PubMed: 21872584PAPER Mizuno T, Doi Y, Mizoguchi H, Jin S, Noda M, Sonobe Y, Takeuchi H, Suzumura A
Interleukin-34 selectively enhances the neuroprotective effects of microglia to attenuate oligomeric amyloid-β neurotoxicity.
Am J Pathol. 2011 Oct;179(4):2016-27. PubMed: 21872563PAPER Lasagna-Reeves CA, Kayed R
Astrocytes contain amyloid-β annular protofibrils in Alzheimer's disease brains.
FEBS Lett. 2011 Oct 3;585(19):3052-7. PubMed: 21872592PAPER Walsh R, Rockwood K, Martin E, Darvesh S
Synergistic inhibition of butyrylcholinesterase by galantamine and citalopram.
Biochim Biophys Acta. 2011 Dec;1810(12):1230-5. PubMed: 21872646PAPER Reddy PH
Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease.
Brain Res. 2011 Sep 30;1415:136-48. PubMed: 21872849PAPER Hieke M, Ness J, Steri R, Greiner C, Werz O, Schubert-Zsilavecz M, Weggen S, Zettl H
SAR studies of acidic dual γ-secretase/PPARγ modulators.
Bioorg Med Chem. 2011 Sep 15;19(18):5372-82. PubMed: 21873070PAPER Cirrito JR, Disabato BM, Restivo JL, Verges DK, Goebel WD, Sathyan A, Hayreh D, D'Angelo G, Benzinger T, Yoon H, Kim J, Morris JC, Mintun MA, Sheline YI
Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans.
Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14968-73. PubMed: 21873225PAPER Calkins MJ, Manczak M, Mao P, Shirendeb U, Reddy PH
Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease.
Hum Mol Genet. 2011 Dec 1;20(23):4515-29. PubMed: 21873260PAPER Kutschenko LK
Diagnostic misconceptions? A closer look at clinical research on Alzheimer's disease.
J Med Ethics. 2012 Jan;38(1):57-9. PubMed: 21873309PAPER Kilger E, Buehler A, Woelfing H, Kumar S, Kaeser SA, Nagarathinam A, Walter J, Jucker M, Coomaraswamy J
BRI2 protein regulates β-amyloid degradation by increasing levels of secreted insulin-degrading enzyme (IDE).
J Biol Chem. 2011 Oct 28;286(43):37446-57. PubMed: 21873424Current Filters
No filters selected